GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder
A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential ...
A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential ...
New research highlights the potential for weight-loss medication to ease arthritis symptoms, offering hope for improved mobility and pain relief. ...
The diabetes drug semaglutide, also known as Ozempic, has a positive effect for patients with chronic kidney damage and obesity. ...
Study shows that semaglutide not only aids in weight loss but also slashes heart failure risk by 76% in overweight ...
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well ...
Patients taking semaglutide injections are less likely to die of any cause, including from cardiovascular disease and infections like COVID-19, ...
Study: Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality. Image Credit: myskin / Shutterstock.com In a recent ...
In a recent study published in the journal Annals of Internal Medicine, a team of researchers from the National Institutes ...
Novo Nordisk today announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions ...
Obesity is a major cause of illness and death, mainly due to cardiovascular disease (CVD), which claims about 18 million ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net